Morgan Stanley’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

Morgan Stanley’s Portfolio CLVT.PRA Stock Details CLVT.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,442	Closed	-$402K	–	8019
2024 Q1	$402K	Sell	13,442 -3,414	-20%	-$116K	﹤0.01%	5408
2023 Q4	$641K	Buy	16,856 +14,639	+660%	+$460K	﹤0.01%	5516
2023 Q3	$64.9K	Buy	2,217 +50	+2%	+$1.74K	﹤0.01%	6058
2023 Q2	$89.4K	Buy	2,167 +600	+38%	+$22.6K	﹤0.01%	6001
2023 Q1	$64.4K	Buy	1,567 +500	+47%	+$22.5K	﹤0.01%	6192
2022 Q4	$40.6K	Buy	1,067 +554	+108%	+$23.3K	﹤0.01%	6381
2022 Q3	$22K	Sell	513 -89,519	-99%	-$4.76M	﹤0.01%	6759
2022 Q2	$5.14M	Sell	90,032 -15,200	-14%	-$931K	﹤0.01%	3731
2022 Q1	$7.12M	Buy	105,232 +8,605	+9%	+$582K	﹤0.01%	3298
2021 Q4	$8.73M	Buy	+96,627	New	+$8.69M	﹤0.01%	3093

Morgan Stanley's CLVT.PRA Position: Q2 2024 in Review

Morgan Stanley sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q2 2024, closing a stake of 13,442 shares — an estimated $402K sold.

Morgan Stanley first reported a position in CLVT.PRA in Q4 2021 and held it in 10 quarters. The position peaked at $8.73M in Q4 2021. 0 funds tracked by Wall St. Rank hold CLVT.PRA as of Q2 2024.

Morgan Stanley reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q2 2024 after selling out during the quarter.
Morgan Stanley sold 13,442 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q2 2024, an estimated $402K.
Morgan Stanley first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q4 2021 and held it in 10 quarters.
Morgan Stanley's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $8.73M in Q4 2021.
0 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.